FIELD: medicine. SUBSTANCE: the method includes isolation of monocytes out of patient's blood, their cultivation with growth factors, addition of antigenic material cells out of patient's tumor to monocyte-obtained dendritic cells and inside, and intracutaneous injection of dendritic cells. Additionally, one should carry out immunomodulation by using patient's activated lymphocytes. The method enables to activate specific antitumor immunity. EFFECT: higher efficiency of therapy. 1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| COMPOSITION FOR TREATING HEPATITIS C AND METHOD OF TREATING HEPATITIS C | 2010 |
|
RU2447899C2 |
| IMMUNOTHERAPY METHOD FOR TREATING PATIENTS FOR SOLID TUMORS BY APPLYING TUMOR LYSATE WITH BETALEUKINE ADJUVANT | 2004 |
|
RU2267326C2 |
| METHOD FOR SELECTING NEUROONCOLOGICAL PATIENTS FOR IMMUNOTHERAPY | 2005 |
|
RU2297632C2 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| COMBINATION CELL IMMUNOTHERAPY OF MALIGNANT TUMORS | 2020 |
|
RU2787623C2 |
| METHOD FOR OBTAINING ANTIGEN SPECIFIC CYTOTOXIC CELLS WITH ANTI-TUMOR CYTOTOXIC ACTIVITY AGAINST CELLS OF NON-SMALL CELLS LUNG CANCER | 2016 |
|
RU2639514C1 |
| METHOD OF GENERATING CYTOTOXIC CELLS WITH ACTIVITY AGAINST NON-SMALL CELL LUNG CANCER CELLS | 2014 |
|
RU2577992C2 |
